PL1668017T3 - Dwusiarczkowe, siarczkowe, sulfotlenkowe i sulfonowe pochodne cukrów cyklicznych i ich zastosowania - Google Patents

Dwusiarczkowe, siarczkowe, sulfotlenkowe i sulfonowe pochodne cukrów cyklicznych i ich zastosowania

Info

Publication number: PL1668017T3
Authority: PL; Poland
Prior art keywords: disulfide; sulfoxide; sulfide; sulfone derivatives; cyclic sugars
Prior art date: 2003-10-03

Application number

PL04765682T

Other languages

English (en)

Inventor

Moliner Jose Repolles

Perez-Rasilla Eduardo Salas

Coy Francisco Pubill

Original Assignee

Lacer Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-10-03

Filing date

2004-09-29

Publication date

2009-07-31

2004-09-29 Application filed by Lacer Sa filed Critical Lacer Sa

2009-07-31 Publication of PL1668017T3 publication Critical patent/PL1668017T3/pl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Diabetes (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Hospice & Palliative Care (AREA)
Endocrinology (AREA)
Neurosurgery (AREA)
Obesity (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Biochemistry (AREA)
Immunology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Toxicology (AREA)
Psychiatry (AREA)
Gynecology & Obstetrics (AREA)
Reproductive Health (AREA)
Dermatology (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PL04765682T 2003-10-03 2004-09-29 Dwusiarczkowe, siarczkowe, sulfotlenkowe i sulfonowe pochodne cukrów cyklicznych i ich zastosowania PL1668017T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
ES200302368A ES2258365B1 (es)	2003-10-03	2003-10-03	Derivados de disulfuro, sulfuro, sulfoxido y sulfona de azucares ciclicos y sus usos.
PCT/EP2004/010882 WO2005037842A1 (en)	2003-10-03	2004-09-29	Disulfide, sulfide, sulfoxide, and sulfone derivatives of cyclic sugars and uses thereof
EP04765682A EP1668017B1 (en)	2003-10-03	2004-09-29	Disulfide, sulfide, sulfoxide, and sulfone derivatives of cyclic sugars and uses thereof

Publications (1)

Publication Number	Publication Date
PL1668017T3 true PL1668017T3 (pl)	2009-07-31

Family

ID=34451643

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL04765682T PL1668017T3 (pl)	2003-10-03	2004-09-29	Dwusiarczkowe, siarczkowe, sulfotlenkowe i sulfonowe pochodne cukrów cyklicznych i ich zastosowania

Country Status (34)

Country	Link
US (3)	US7521571B2 (pl)
EP (1)	EP1668017B1 (pl)
JP (2)	JP4809769B2 (pl)
KR (1)	KR101141683B1 (pl)
CN (1)	CN1863805B (pl)
AP (1)	AP1976A (pl)
AR (1)	AR045962A1 (pl)
AT (1)	ATE423781T1 (pl)
AU (1)	AU2004281916B2 (pl)
BR (1)	BRPI0415020A (pl)
CA (1)	CA2540500C (pl)
DE (2)	DE602004019666D1 (pl)
DK (1)	DK1668017T3 (pl)
EA (1)	EA008942B1 (pl)
EC (1)	ECSP066542A (pl)
ES (2)	ES2258365B1 (pl)
GB (1)	GB2421241B (pl)
GE (1)	GEP20084490B (pl)
GT (1)	GT200400200A (pl)
HR (1)	HRP20090152T3 (pl)
IL (1)	IL174371A0 (pl)
IS (1)	IS8436A (pl)
MX (1)	MXPA06003610A (pl)
NO (1)	NO20061872L (pl)
NZ (1)	NZ546043A (pl)
PA (1)	PA8614201A1 (pl)
PE (1)	PE20050436A1 (pl)
PL (1)	PL1668017T3 (pl)
PT (1)	PT1668017E (pl)
RS (1)	RS20060241A (pl)
SI (1)	SI1668017T1 (pl)
UY (1)	UY28547A1 (pl)
WO (1)	WO2005037842A1 (pl)
ZA (1)	ZA200603475B (pl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2258365B1 (es)	2003-10-03	2007-12-01	Lacer, S.A.	Derivados de disulfuro, sulfuro, sulfoxido y sulfona de azucares ciclicos y sus usos.
EP1941876A1 (en) *	2006-12-28	2008-07-09	Lacer, S.A.	Isosorbide mononitrate derivatives for the treatment of Inflammation and ocular hypertension
ES2332565B1 (es) *	2007-01-23	2010-10-21	Lacer, S.A.	Uso de derivados de mononitrato de dianhidrohexita como agentes antiinflamatorios.
US20080193530A1 (en) *	2007-02-13	2008-08-14	Brent Blackburn	Use of ranolazine for the treatment of non-coronary microvascular diseases
JP2010518170A (ja) *	2007-02-13	2010-05-27	ギリアード・パロ・アルト・インコーポレイテッド	冠微小血管疾患の処置のためのラノラジンの使用
US20090111826A1 (en) *	2007-02-13	2009-04-30	Louis Lange	Use of ranolazine for the treatment of cardiovascular diseases
EP2117509A1 (en) *	2007-02-13	2009-11-18	CV Therapeutics Inc.	Use of ranolazine for the treatment of cardiovascular diseases
WO2008116083A1 (en) *	2007-03-22	2008-09-25	Cv Therapeutics, Inc.	Use of ranolazine for elevated brain-type natriuretic peptide
ES2402675T3 (es) *	2007-05-31	2013-05-07	Gilead Palo Alto, Inc.	Ranolazina para el péptido natriurético de tipo cerebral a niveles elevados
IE20070934A1 (en)	2007-12-21	2009-06-24	Trinity College Dublin	Efficient aspirin prodrugs
WO2009098113A1 (en) *	2008-02-07	2009-08-13	Nicox S.A.	Nitric oxide donor compounds
EP2149576A1 (en)	2008-07-22	2010-02-03	Lacer, S.A.	Isosorbide Nitrates having vasodilating activity
EP2149577B1 (en) *	2008-07-22	2011-04-27	Lacer, S.A.	New stereospecific method for the preparation of dioxa-bicyclooctane compounds
EP2177216A1 (en) *	2008-10-13	2010-04-21	Lacer, S.A.	Use of dianhydrohexite mononitrate derivatives as healing agents
WO2010055138A1 (en) *	2008-11-14	2010-05-20	Lacer, S.A.	New stereospecific method for the preparation of dioxa-bicyclooctane compounds
EP2199294A1 (en)	2008-12-19	2010-06-23	Lacer, S.A.	New stereospecific method for the preparation of dioxa bicyclooctane nitrate compounds
CA2822747A1 (en) *	2009-12-23	2011-06-30	Arca Biopharma, Inc.	Use of s-(6-nitro-oxi-hexahydro-furo[3,2-b]thioacetate in the treatment of cardiovascular disorders associated with oxide synthase dysfunction
FR2977252B1 (fr) *	2011-06-30	2013-08-02	Seppic Sa	Nouveaux esters de derives n-acyles d'acides amines et d'isosorbide, procede pour leur preparation, et utilisation en cosmetique et comme medicament.
IN2014CN04434A (pl)	2011-12-16	2015-09-04	3M Innovative Properties Co
AU2014226533A1 (en) *	2013-03-05	2015-08-13	Archer Daniels Midland Company	Isohexide monotriflates and process for synthesis thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1356374A (en) *	1971-04-29	1974-06-12	American Home Prod	Mononitrate esters of 1,3 3,6-dianhydro-d-glucitol
US3886186A (en)	1971-04-29	1975-05-27	American Home Prod	Mononitrate esters of 1,4:3,6-dianhydro-d-glucitol
DE3102947A1 (de)	1981-01-29	1982-09-02	Heinrich Mack Nachf., 7918 Illertissen	Verfahren zur herstellung von isosorbid-5-nitrat
IT1204571B (it) *	1987-05-08	1989-03-10	Chiesi Farma Spa	Esteri di 1,4:3,6-dianidrosorbitolo-2-mononitrato e 5-mononitrato,loro procedimento di preparazione e loro composizioni farmaceutiche
US4891373A (en) *	1988-11-23	1990-01-02	Pfizer Inc.	Aminopropanol derivatives of 1,4:3,6-dianhydrohexitol nitrates, processes for their preparation and their use as medicaments
FR2680173A1 (fr) *	1991-08-07	1993-02-12	Hoechst Lab	Nitrates organiques, leurs procedes de preparation et leur utilisation dans le traitement de maladies cardiovasculaires .
DE69321596T2 (de) *	1992-07-30	1999-04-22	Cal International Ltd., Dublin	Ester und kombinationen von einem organischen nitrat und einem salicyclat
DE4410997A1 (de) *	1994-03-30	1995-10-26	Isis Pharma Gmbh	Pharmazeutische Zubereitungen und Arzneistoffe zur Prävention und Behandlung endothelialer Dysfunktionen
IL120531A (en) *	1997-03-26	2006-12-31	Yissum Res Dev Co	Nitric oxide donors and pharmaceutical compositions containing them
ES2142773B1 (es) *	1998-10-07	2001-01-01	Lacer Sa	Derivados de mononitrato de isosorbida y su empleo como agentes vasodilatadores con tolerancia desminuida.
US20020013483A1 (en) *	2000-07-13	2002-01-31	Consortium Fur Elektrochemische Industrie Gmbh	Process for the preparation of dianhydrohexitol bisacylates
EP1337283A4 (en) *	2000-10-27	2005-05-18	Nitromed Inc	METHODS OF TREATING VASCULAR DISEASES CHARACTERIZED BY NITROGEN MONOXIDE INSUFFICIENCY
UA63467A (en)	2003-04-22	2004-01-15		Pharmaceutical composition of organic nitrates, dosage form based on pharmaceutical composition of organic nitrates and method of manufacture
ES2258365B1 (es) *	2003-10-03	2007-12-01	Lacer, S.A.	Derivados de disulfuro, sulfuro, sulfoxido y sulfona de azucares ciclicos y sus usos.

2003
- 2003-10-03 ES ES200302368A patent/ES2258365B1/es not_active Expired - Fee Related
2004
- 2004-09-29 DK DK04765682T patent/DK1668017T3/da active
- 2004-09-29 PT PT04765682T patent/PT1668017E/pt unknown
- 2004-09-29 AU AU2004281916A patent/AU2004281916B2/en not_active Ceased
- 2004-09-29 GE GEAP20049372A patent/GEP20084490B/en unknown
- 2004-09-29 HR HR20090152T patent/HRP20090152T3/xx unknown
- 2004-09-29 ES ES04765682T patent/ES2322468T3/es not_active Expired - Lifetime
- 2004-09-29 DE DE602004019666T patent/DE602004019666D1/de not_active Expired - Lifetime
- 2004-09-29 DE DE112004001860T patent/DE112004001860T5/de not_active Withdrawn
- 2004-09-29 NZ NZ546043A patent/NZ546043A/en unknown
- 2004-09-29 KR KR1020067006283A patent/KR101141683B1/ko not_active Expired - Fee Related
- 2004-09-29 AT AT04765682T patent/ATE423781T1/de not_active IP Right Cessation
- 2004-09-29 EA EA200600694A patent/EA008942B1/ru not_active IP Right Cessation
- 2004-09-29 GB GB0605574A patent/GB2421241B/en not_active Expired - Fee Related
- 2004-09-29 CN CN2004800289355A patent/CN1863805B/zh not_active Expired - Fee Related
- 2004-09-29 CA CA2540500A patent/CA2540500C/en not_active Expired - Fee Related
- 2004-09-29 PL PL04765682T patent/PL1668017T3/pl unknown
- 2004-09-29 BR BRPI0415020-1A patent/BRPI0415020A/pt not_active IP Right Cessation
- 2004-09-29 SI SI200431109T patent/SI1668017T1/sl unknown
- 2004-09-29 MX MXPA06003610A patent/MXPA06003610A/es active IP Right Grant
- 2004-09-29 AP AP2006003605A patent/AP1976A/xx active
- 2004-09-29 WO PCT/EP2004/010882 patent/WO2005037842A1/en not_active Ceased
- 2004-09-29 RS YUP-2006/0241A patent/RS20060241A/sr unknown
- 2004-09-29 JP JP2006530042A patent/JP4809769B2/ja not_active Expired - Fee Related
- 2004-09-29 US US10/544,237 patent/US7521571B2/en not_active Expired - Fee Related
- 2004-09-29 EP EP04765682A patent/EP1668017B1/en not_active Expired - Lifetime
- 2004-09-30 PE PE2004000957A patent/PE20050436A1/es not_active Application Discontinuation
- 2004-10-01 UY UY28547A patent/UY28547A1/es not_active Application Discontinuation
- 2004-10-01 GT GT200400200A patent/GT200400200A/es unknown
- 2004-10-01 AR ARP040103576A patent/AR045962A1/es unknown
- 2004-10-01 PA PA20048614201A patent/PA8614201A1/es unknown
2006
- 2006-03-16 IL IL174371A patent/IL174371A0/en unknown
- 2006-04-27 NO NO20061872A patent/NO20061872L/no not_active Application Discontinuation
- 2006-05-02 ZA ZA200603475A patent/ZA200603475B/xx unknown
- 2006-05-03 EC EC2006006542A patent/ECSP066542A/es unknown
- 2006-05-03 IS IS8436A patent/IS8436A/is unknown
2009
- 2009-03-09 US US12/400,394 patent/US7777058B2/en not_active Expired - Fee Related
2010
- 2010-04-06 US US12/755,103 patent/US8541607B2/en not_active Expired - Fee Related
- 2010-10-08 JP JP2010228789A patent/JP2011012081A/ja active Pending

Also Published As

Publication number	Publication date
ZA200603475B (en)	2007-09-26
IS8436A (is)	2006-05-03
CN1863805B (zh)	2010-06-16
SI1668017T1 (sl)	2009-08-31
US8541607B2 (en)	2013-09-24
UY28547A1 (es)	2005-04-29
IL174371A0 (en)	2006-08-01
RS20060241A (sr)	2008-06-05
GEP20084490B (en)	2008-09-25
GT200400200A (es)	2005-05-23
KR101141683B1 (ko)	2012-05-07
US20100196387A1 (en)	2010-08-05
GB2421241A (en)	2006-06-21
PA8614201A1 (es)	2005-05-24
US7521571B2 (en)	2009-04-21
PT1668017E (pt)	2009-03-09
MXPA06003610A (es)	2006-06-05
EA008942B1 (ru)	2007-10-26
CN1863805A (zh)	2006-11-15
WO2005037842A1 (en)	2005-04-28
ES2322468T3 (es)	2009-06-22
BRPI0415020A (pt)	2006-11-07
JP2011012081A (ja)	2011-01-20
GB2421241B (en)	2008-04-16
NO20061872L (no)	2006-06-30
EA200600694A1 (ru)	2006-10-27
DE602004019666D1 (de)	2009-04-09
HRP20090152T3 (en)	2009-05-31
AR045962A1 (es)	2005-11-16
EP1668017A1 (en)	2006-06-14
NZ546043A (en)	2009-02-28
AP1976A (en)	2009-03-16
KR20060066743A (ko)	2006-06-16
CA2540500C (en)	2012-08-28
ECSP066542A (es)	2006-10-17
CA2540500A1 (en)	2005-04-28
HK1092807A1 (en)	2007-02-16
AU2004281916A1 (en)	2005-04-28
AP2006003605A0 (en)	2006-04-30
JP4809769B2 (ja)	2011-11-09
ATE423781T1 (de)	2009-03-15
JP2007507451A (ja)	2007-03-29
ES2258365A1 (es)	2006-08-16
US20060235052A1 (en)	2006-10-19
EP1668017B1 (en)	2009-02-25
ES2258365B1 (es)	2007-12-01
GB0605574D0 (en)	2006-04-26
DK1668017T3 (da)	2009-05-11
US20090169560A1 (en)	2009-07-02
DE112004001860T5 (de)	2006-07-27
US7777058B2 (en)	2010-08-17
AU2004281916B2 (en)	2010-10-21
PE20050436A1 (es)	2005-06-23

Publication	Publication Date	Title
AP1976A (en)	2009-03-16	Disulfide, sulfide, sulfoxide and sulfone derivatives of cyclic sugars and uses thereof
DK1604915T4 (da)	2020-01-02	Lukket kapsel med åbningsorgan
ATE556593T1 (de)	2012-05-15	Herbizide enthaltend substituierte thien-3-yl- sulfonylamino(thio)carbonyltriazolin(thi)one und flurtamone
HUS1600006I1 (hu)	2016-02-29	Helyettesített tien-3-il-szulfonilamino(tio)karboniltriazolin(ti)on-on és 4-HPPD inhibitorokon alapuló gyomirtó készítmények
IL195610A0 (en)	2009-09-01	Neural networks with learning and expression capability
EP1953194A4 (en)	2009-09-16	Polyarylene sulfide compound
ATE407172T1 (de)	2008-09-15	Schwefelpellet mit h2s-unterdrückungsmittel
NO20053564D0 (no)	2005-07-20	Bis(3)-alkoksyalkan-2-ol)sulfider, sulfoner og sulfoksider: nye overflateaktive midler.
ATE354566T1 (de)	2007-03-15	Aromatische sulfone und deren medizinische verwendung
FI20020614A0 (fi)	2002-03-28	Henkilökohtainen viestinlaite, jossa on kaksi osaa ja korostuneet mahdollisuudet itseilmaisuun
IL185400A0 (en)	2008-02-09	Synthesis of (e) -alpha, beta unsaturated sulfides, sulfones, sulfoxides and sulfonamides
EP2046322A4 (en)	2010-10-06	ARYL-VINYL-SULFIDE, -SULFONE, -SULFOXIDE AND -SULFONAMIDES, DERIVATIVES THEREOF AND THERAPEUTIC APPLICATIONS THEREOF
DE60333700D1 (de)	2010-09-23	CAM Zelle
IL179419A0 (en)	2007-05-15	Heteroaryl sulfones and sulfonamides and therapeutic uses thereof
ATE412645T1 (de)	2008-11-15	Substituierte thiophene und deren verwendungen
PL374201A1 (pl)	2005-10-03	Pochodne tiofenu jako środki przeciw robakom i owadobójcze
ITBO20050394A1 (it)	2005-09-07	Pacchetto per il contenimento di articoli sfusi sbozzato per la realizzazione di tale pacchetto e metodo di piegatura di tale sbozzato
AU2003235697A1 (en)	2003-07-30	Phenyl sulfoxides and phenyl sulfones
ITMI20020772A0 (it)	2002-04-10	Meccanismo per ante scorrevoli
AP2022A (en)	2009-08-10	Pesticidal treatment of stored foodstuffs, chambers, structures and works of art with sulphur compounds
AU2003215665A1 (en)	2003-10-08	Probucol derivatives
DE60316668D1 (de)	2007-11-15	Kautschukzusammensetzung, vulkanisierbare kautschukzusammensetzung und vulkanisat
AU2003293573A1 (en)	2004-07-22	Bow limb fixation member
DE50300554D1 (de)	2005-06-23	Schiebetor
TW517772U (en)	2003-01-11	Integral structure of auto-door with capable of overall open function